Invention Grant
- Patent Title: Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
-
Application No.: US16002888Application Date: 2018-06-07
-
Publication No.: US10195223B2Publication Date: 2019-02-05
- Inventor: Herriot Tabuteau
- Applicant: ANTECIP BIOVENTURES II LLC
- Applicant Address: US NY New York
- Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee Address: US NY New York
- Agency: Maschoff Brennan
- Agent Brent A. Johnson; Yuefen Zhou
- Main IPC: A61K31/663
- IPC: A61K31/663 ; A61K31/675 ; A61K31/4164 ; A61K9/20 ; A61K9/00 ; A61K31/4172 ; C07D233/60 ; A61K9/48 ; C07F9/6506
Abstract:
Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form, can be used to treat or alleviate pain or related conditions.
Public/Granted literature
- US20180280416A1 DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE Public/Granted day:2018-10-04
Information query
